What is Proxim Diagnostics?
Proxim Diagnostics is at the forefront of developing innovative handheld immunodiagnostic devices designed to perform essential laboratory tests directly at the point of care. Their technology leverages whole blood to provide crucial diagnostic information to healthcare providers, particularly in time-sensitive environments like emergency departments, without sacrificing sensitivity or precision. The company's focus on high-performance, low-cost disposable test cartridges aims to make advanced diagnostics accessible across various global healthcare settings. Proxim Diagnostics targets hospitals and healthcare providers seeking efficient and reliable diagnostic solutions for a range of conditions, including women's health, cardiology, and infectious diseases.
How much funding has Proxim Diagnostics raised?
Proxim Diagnostics has raised a total of $2.3M across 1 funding round:
Private Equity
$2.3M
Private Equity (2016): $2.3M, investors not publicly disclosed
What's next for Proxim Diagnostics?
With significant enterprise-level funding, Proxim Diagnostics is strategically positioned for substantial growth and market penetration. The company's focus on point-of-care diagnostics addresses a critical need for rapid, accurate testing in diverse healthcare settings. Future developments are likely to center on expanding their portfolio of test cartridges, enhancing device capabilities, and forging strategic partnerships to broaden their global reach. Continued investment will enable Proxim Diagnostics to scale its operations, further refine its technology, and solidify its position as a leader in the rapidly evolving field of handheld diagnostics.
See full Proxim Diagnostics company page
